Nyxoah

Price Chart

Risk-Adjusted Performance

Also Listed On

Nyxoah (NYXH) Price Performance

Nyxoah (NYXH) trades on BR in EUR. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at EUR2.77, up 0.36% from the previous close.

Over the past year, NYXH has traded between a low of EUR2.40 and a high of EUR7.70. The stock has lost 48.6% over this period. It is currently 64.0% below its 52-week high.

Nyxoah has a market capitalization of $121.16M.

About Nyxoah

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.